Table 1.
Drug delivery | Regenerative medicine | |
---|---|---|
Definitions | In which exosomal cargo is modified to contain a specific compound, including but not limited to a particular protein, miRNA, or pharmaceutical drug, for treatment | In which exosomes are used as naturally produced for treatment |
Number of Papers | 360 | 338 |
Number of Clinical Trials | 2 | 13 |
Pros | Highly specific organotropic behaviour [6,15] Biocompatible [6] Can be engineered to increase drug load or improve stability and targeting ability [6,12,15] Stable during cryopreservation [16] Naturally crosses cell membranes and the BBB [30,54] Avoid macrophage uptake, resulting in long blood circulation [54] Large surface area to volume ratio allows exosomes to carry a significant amount of surface cargo [4] Can carry hydrophobic and hydrophilic drugs [15] |
Highly specific organotrophic behaviour [40,48,54, B. 18,26] Nonimmunogenic [54] Can be selected to carry specific proteins, receptors, or nucleic acids for gene therapy via cell culture microenvironment [9,16,35,64, B. 26] Stable during cryopreservation [16] Naturally crosses cell membranes and the BBB [63] Regulate tissue homoeostasis [36,54] Initiates tissue repair and regeneration [2,17,34,36,40,48] Released by most cell types, enabling tissue-specific signalling [48,54] Long-lasting paracrine effects [39,40] |
Cons | Difficult to produce enough yield to be effective in
humans [6] All isolation techniques have cons, including time, monetary cost, forming aggregates, introducing contaminants [6,54] Systemic administration has not reflected targeting potential [6] |
Difficult to produce enough yield to be effective in
humans [10,64] All isolation techniques have cons, including time, monetary cost, forming aggregates, introducing contaminants [16,63,66] No single way to manufacture exosomes of a specific potency [10,16] |
Representative Companies | Anjarium Biosciences ArunA Biomedical Codiak Biosciences Evox Therapeutics Exogenus Therapeutics |
Aegle Therapeutics BreStem Therapeutics Capricor Therapeutics Kimera Exosomes ReNeuron Tavec Pharma Xollent Biotech |